Table 1.
Demographic and clinical data of the whole group, also distributed for sex.
Demographic and Clinical Data | Total (n = 103) | Man (n = 59) | Woman (n = 44) | p Value |
---|---|---|---|---|
Age (Mean ± SD) | 55 ± 14.65 | 56 ± 13.86 | 52.35 ± 15.64 | ns |
Temperature (Mean ± SD) | 36 ± 0.45 | 36 ± 0.42 | 36.36 ± 0.49 | ns |
Inflammatory serum markers | ||||
WBC (x109/L) (Mean ± SD) | 8.55 ± 6.23 | 9.65 ± 7.44 | 6.61 ± 2.15 | 0.0082 |
Neutrophil, count (Mean ± SD) | 5.9 ± 5.23 | 6.69 ± 6.18 | 4.5 ± 2.44 | 0.0136 |
Lymphocyte, count (Mean ± SD) | 2.09 ± 4.35 | 2.41 ± 5.43 | 1.54 ± 0.65 | ns |
Neutrophil, %WB (Mean ± SD) | 65.9 ± 18.7 | 0.67 ± 0.2 | 0.64 ± 0.15 | ns |
Lymphocyte, %WB (Mean ± SD) | 24.22 ± 15.84 | 0.23 ± 0.17 | 0.25 ± 0.13 | ns |
CRP (Mean ± SD) | 19.97 ± 34.56 | 21.49 ± 34.25 | 17.31 ± 34.92 | 0.0024 |
sNS | ||||
0n (%) | 9 (8.74) | 5 (8.47) | 4 (9.09) | ns |
1–2n (%) | 26 (25.24) | 19 (32.2) | 7 (15.91) | ns |
≥ 3n (%) | 68 (66.02) | 35 (59.32) | 33 (75) | ns |
sNS distribution | ||||
Any n (%) | 94 (91.3) | 54 (91.52) | 40 (90.9) | ns |
Hyposmia n (%) | 40 (38.83) | 16 (27.12) | 24 (55.54) | 0.0047 |
Dysgeusia n (%) | 48 (46.60) | 20 (33.9) | 28 (63.63) | 0.0028 |
Auditory Dysfunction n (%) | 2 (1.94) | 0 (0) | 2 (5.26) | ns |
Headache n (%) | 40 (38.83) | 16 (27.12) | 24 (54.54) | 0.0047 |
Confusion n (%) | 23 (22.33) | 12 (20.34) | 11 (25) | ns |
Dizziness n (%) | 27 (26.21) | 11 (18.64) | 16 (36.36) | 0.0431 |
Numbness/Paresthesia n (%) | 6 (5.8) | 0 (0) | 6 (13.63) | 0.0035 |
Fatigue n (%) | 33 (32.04) | 22 (37.29) | 11 (25) | ns |
Daytime Sleepiness n (%) | 34 (33.01) | 13 (22.03) | 21 (47.72) | 0.0061 |
Sleep Impairment n (%) | 51 (49.51) | 33 (55.93) | 18 (40.9) | ns |
Muscle Ache n (%) | 25 (24.27) | 8 (13.56) | 17 (38.63) | 0.0033 |
Depression n (%) | 39 (37.86) | 19 (32.20) | 20 (45.45) | ns |
Anxiety n (%) | 34 (33.01) | 18 (30.51) | 16 (36.36) | ns |
List of abbreviations: n, Number of patients; SD, Standard Deviation; WBC, white blood cells; CRP, C-reactive protein; sNS, Subjective Neurological Symptoms; ns, Not Significant.